WO2001075069A1 - Procede de production de lipides et micro-organismes secretant des lipides - Google Patents
Procede de production de lipides et micro-organismes secretant des lipides Download PDFInfo
- Publication number
- WO2001075069A1 WO2001075069A1 PCT/JP2000/002129 JP0002129W WO0175069A1 WO 2001075069 A1 WO2001075069 A1 WO 2001075069A1 JP 0002129 W JP0002129 W JP 0002129W WO 0175069 A1 WO0175069 A1 WO 0175069A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lipid
- cells
- acid
- medium
- microorganism
- Prior art date
Links
- 150000002632 lipids Chemical class 0.000 title claims abstract description 75
- 244000005700 microbiome Species 0.000 title claims abstract description 53
- 238000000034 method Methods 0.000 title claims description 12
- 230000003248 secreting effect Effects 0.000 title abstract description 17
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 28
- 108010087894 Fatty acid desaturases Proteins 0.000 claims abstract description 21
- 102000009114 Fatty acid desaturases Human genes 0.000 claims abstract description 11
- 238000012258 culturing Methods 0.000 claims abstract description 11
- 229960004488 linolenic acid Drugs 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims abstract description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 39
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 33
- 238000004519 manufacturing process Methods 0.000 claims description 28
- 241000235070 Saccharomyces Species 0.000 claims description 11
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 11
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 11
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 9
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 6
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims description 3
- 239000000758 substrate Substances 0.000 claims description 3
- JIWBIWFOSCKQMA-GFRMADBLSA-N (6e,9e,12e,15e)-octadeca-6,9,12,15-tetraenoic acid Chemical compound CC\C=C\C\C=C\C\C=C\C\C=C\CCCCC(O)=O JIWBIWFOSCKQMA-GFRMADBLSA-N 0.000 abstract description 5
- 239000002609 medium Substances 0.000 description 54
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 25
- 239000002253 acid Substances 0.000 description 24
- 239000000243 solution Substances 0.000 description 18
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 15
- 238000005119 centrifugation Methods 0.000 description 15
- 239000008103 glucose Substances 0.000 description 15
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 14
- 229910052757 nitrogen Inorganic materials 0.000 description 13
- 239000012228 culture supernatant Substances 0.000 description 12
- 235000014113 dietary fatty acids Nutrition 0.000 description 12
- 229930195729 fatty acid Natural products 0.000 description 12
- 239000000194 fatty acid Substances 0.000 description 12
- 150000004665 fatty acids Chemical class 0.000 description 11
- 239000013612 plasmid Substances 0.000 description 11
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 10
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 10
- 235000011130 ammonium sulphate Nutrition 0.000 description 10
- 239000002299 complementary DNA Substances 0.000 description 10
- 239000003925 fat Substances 0.000 description 10
- 235000019197 fats Nutrition 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 150000001413 amino acids Chemical group 0.000 description 9
- 235000020778 linoleic acid Nutrition 0.000 description 9
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 9
- 229920001817 Agar Polymers 0.000 description 8
- 239000008272 agar Substances 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 7
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 7
- 229930182830 galactose Natural products 0.000 description 7
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- PLUBXMRUUVWRLT-UHFFFAOYSA-N Ethyl methanesulfonate Chemical compound CCOS(C)(=O)=O PLUBXMRUUVWRLT-UHFFFAOYSA-N 0.000 description 6
- 229940041514 candida albicans extract Drugs 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 239000012138 yeast extract Substances 0.000 description 6
- 102100037777 Galactokinase Human genes 0.000 description 5
- 101001066237 Treponema pallidum (strain Nichols) Putative galactokinase Proteins 0.000 description 5
- 230000005484 gravity Effects 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000013598 vector Substances 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 108010037138 Linoleoyl-CoA Desaturase Proteins 0.000 description 4
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 235000021588 free fatty acids Nutrition 0.000 description 4
- -1 iron ion Chemical class 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 150000003626 triacylglycerols Chemical class 0.000 description 4
- 239000007222 ypd medium Substances 0.000 description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 241000235395 Mucor Species 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 239000007984 Tris EDTA buffer Substances 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000000432 density-gradient centrifugation Methods 0.000 description 3
- LMBMDLOSPKIWAP-UHFFFAOYSA-N embutramide Chemical compound OCCCC(=O)NCC(CC)(CC)C1=CC=CC(OC)=C1 LMBMDLOSPKIWAP-UHFFFAOYSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000004817 gas chromatography Methods 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 102100034544 Acyl-CoA 6-desaturase Human genes 0.000 description 2
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 229910015900 BF3 Inorganic materials 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000722877 Borago Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 230000005526 G1 to G0 transition Effects 0.000 description 2
- 108010011449 Long-chain-fatty-acid-CoA ligase Proteins 0.000 description 2
- 241000907999 Mortierella alpina Species 0.000 description 2
- 241000223230 Trichosporon Species 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000013611 chromosomal DNA Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 2
- 239000000411 inducer Substances 0.000 description 2
- 229910001410 inorganic ion Inorganic materials 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 108010002995 rat delta 6-desaturase Proteins 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 2
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 241001149952 Amylomyces rouxii Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 102000005870 Coenzyme A Ligases Human genes 0.000 description 1
- 241001527609 Cryptococcus Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 241000235646 Cyberlindnera jadinii Species 0.000 description 1
- MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 101150039661 FAA1 gene Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 241001149669 Hanseniaspora Species 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 241001149698 Lipomyces Species 0.000 description 1
- 241001149691 Lipomyces starkeyi Species 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 102100033995 Long-chain-fatty-acid-CoA ligase 1 Human genes 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- WAEMQWOKJMHJLA-UHFFFAOYSA-N Manganese(2+) Chemical compound [Mn+2] WAEMQWOKJMHJLA-UHFFFAOYSA-N 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 108020005091 Replication Origin Proteins 0.000 description 1
- 241000235003 Saccharomycopsis Species 0.000 description 1
- 241000311088 Schwanniomyces Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 241000235013 Yarrowia Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000005757 colony formation Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- DNVPQKQSNYMLRS-APGDWVJJSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-APGDWVJJSA-N 0.000 description 1
- 150000002137 ergosterols Chemical class 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229910001437 manganese ion Inorganic materials 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0083—Miscellaneous (1.14.99)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6463—Glycerides obtained from glyceride producing microorganisms, e.g. single cell oil
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6472—Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
Definitions
- the present invention relates to a microorganism that secretes lipids, particularly unsaturated fatty acids, out of cells, and a method for producing lipids using the same.
- a method for producing an oil or fat by a fermentation method using a microorganism a method using a yeast belonging to the genus Saccharomyces is known.
- a method for producing lipid components (including triglycerides) having a high palmitoleic acid content using yeast of the genus Saccharomyces Japanese Patent Application Laid-Open No. 63-287491), Production is known (JP-A-62-289191).
- Saccharomyces yeast requires a process of extracting oils and fats from the cells in order to accumulate oils and fats in the cells. This step is complicated and inefficient, including separation of the cells from the culture solution, disruption of the cells, and extraction of the fat or oil with the solvent, or extraction of the fat or oil with the solvent from the dried cells.
- a method for producing fats and oils outside the cells by culturing in the presence of fatty acid alkyl esters or fatty acids belonging to the genera Trichosporon, Saccharomycopsis, Candida or Cryptococcus (Japanese Patent Application Laid-Open No. 5-91889) ), And a microorganism belonging to the genus Trichosporon and capable of producing fats and oils outside the cells by culturing in the presence of carbohydrates, and culturing the cells in a medium containing carbohydrates
- a method for producing fats and oils has been proposed, which comprises producing and accumulating fats and oils from the culture solution and collecting the fats and oils produced and accumulated from the culture solution (Japanese Patent Application Laid-Open No.
- the fats and oils produced extracellularly by these methods are triglycerides, and free fatty acids are not secreted. Furthermore, a method of producing long-chain fatty acids extracellularly using a mutant strain of Candida lypolytica (Miyagawa et al., Agri Biol. Chem., 48, 499 (1984)) is known. It should be noted that Candida's repoliticity is now classified in the genus Yarrowia.
- the mutant strain is obtained by mutating a parent strain deficient in acyl-CoA synthetase I and incapable of degrading fatty acids through ⁇ -oxidation, and screening for a strain exhibiting low cell density by Percoll density gradient centrifugation.
- a strain obtained by screening strains that overlay the acid-auxotrophic mutants and support the growth of those mutants, producing more than 1 mg of fatty acids per ml under optimal conditions I do.
- Saccharomyces cerivisiae into which the rat ⁇ 6 desaturase gene has been introduced, contains linoleic acid in the medium. Is known to be taken up into cells and converted into monolinolenic acid and accumulated in the cells (Biochem. Biophys. Res. Commun., 255 (3), 575 (1999)). Saccharomyces cerevisiae, which has been introduced with the ⁇ 6 desaturylase gene and the 112 desaturase gene isolated from Mortierella alpina, is known to produce GLA from sugars and accumulate in the cells. (Lipids, 34 (7), 649 (1999)).
- An object of the present invention is to provide a microorganism into which a fatty acid desaturase gene is introduced and secretes lipids, particularly unsaturated fatty acids, and a method for producing lipids using the microorganism.
- the present inventors have conducted intensive studies in order to solve the above-mentioned problems, and as a result, have found that, when a fatty acid desaturase gene is introduced into a microorganism capable of secreting lipid, unsaturated fatty acids can be secreted efficiently. They have found and completed the present invention. That is, the present invention is as follows.
- a transformant of a microorganism which is transformed with a gene encoding a fatty acid desaturase and has the ability to secrete lipids outside the cells.
- a method for producing lipid which comprises culturing a transformant of the microorganism of any one of (1;) to (7) in a liquid medium and accumulating lipid in the medium.
- the microorganism of the present invention is a transformant of a microorganism which is transformed with a gene encoding a fatty acid desaturase and has the ability to secrete lipids outside the cells.
- the transformant of the microorganism of the present invention can be obtained, for example, by transforming a host microorganism having an ability to secrete lipids outside the cells with a fatty acid desaturase gene.
- the host microorganism may be a microorganism that has the ability to secrete lipids, or may be a mutant or recombinant microorganism that has acquired the ability to secrete lipids.
- the microorganism of the present invention can also be obtained by imparting the ability to secrete lipid to a transformant of the microorganism into which the fatty acid desaturase gene has been introduced.
- the host of the microorganism of the present invention is not particularly limited as long as it has a fatty acid secreting ability or can impart the fatty acid secreting ability.
- Saccharomyces cerevisiae Saccharomyces '' Saccharomyces yeasts such as Carlsbergensis, Shizosaccharomyces yeasts, Schwanniomyces yeasts, Kloeckera yeasts, Tricosporon yeasts, Cryptococcal yeasts Yeasts such as the genus yeast, yeasts belonging to the genus Candida (Candida lipolyticity, Candida utilis), yeasts such as lipomyces yeast such as Lipomyces starkeyi, and mucor 'ruxi- (Mucor rouxii), Mucor cicinelloides, Mortierella alpina, and other filamentous fungi.
- Saccharomyces cerevisiae Saccharomyces '' Saccharomyces yeasts such as Carlsbergensis, Shizosaccharomyces
- host microorganisms having the ability to secrete lipids include Candida-lipolyticity lipid-secreting mutants (Takagawa et al., Agri Biol. Chem., 48, 499 (1984)) and Saccharomyces cerepiche described later.
- SFS-1 strain which is a mutant of the lipid secretion, and the like.
- lipid-secreting mutants of microorganisms can be prepared by subjecting microorganisms to conventional mutagenesis, for example, sudden mutations such as ethyl methanesulfonate (EMS) and N-methyl-1N, 1-nitro-1N-nitrosoguanidine (NTG). It can be obtained by treating by chemical treatment with a mutagenic agent or physical treatment such as UV irradiation and selecting a mutant that has become secreted by lipids.
- Mutants that secrete lipids can be obtained by converting the mutated microorganism into a low-nitrogen source medium, for example, a carbon source content of 0.8% or more in terms of carbon atoms and a nitrogen source content in terms of nitrogen atoms.
- the cells can be selected by culturing the cells in a medium having a concentration of not more than 0.002%, fractionating the obtained cells by density gradient centrifugation, and selecting a strain to be separated as a high specific gravity fraction.
- a colony of the selected candidate strain is formed on an agar medium, and an agar medium in which a fatty acid-requiring mutant is suspended is overlaid thereon, and a strain on which the fatty acid-requiring mutant grows is grown. By separating, a lipid secreting strain is obtained.
- the mutant used in the present invention may be a spontaneous mutant.
- a lipid secreting strain can be selected by fractionating microbial cells cultured in a specific medium by specific gravity. This is because, when cultured in a low nitrogen source medium as described above, even microorganisms that do not naturally produce excess lipid will produce excess lipid, and lipid secreting strains will This is probably because lipids such as fatty acids are less likely to accumulate in cells than strains, and therefore have a higher specific gravity.
- Saccharomyces cerevisiae SFS-1 strain is a mutant strain obtained as described above.
- microorganisms that secrete fatty acids include mutants or recombinants deficient in long-chain acyl-C0A synthase (EC 6.2.1.3).
- the present inventors cloned a gene that reverses the mutation of SF S-red, and found that it had the same sequence as the known FAA1 gene, and it was found that FAA is a fatty acid non-secreting strain of Saccharomyces cerevisiae. We have discovered that disruption of one gene results in secretion of lipids.
- the fatty acid desaturase gene to be introduced into a microorganism capable of secreting lipids is not particularly limited as long as it is pluripotent in the host microorganism, but is not limited to the ⁇ 5 desaturylase gene, ⁇ 6 desaturylase gene, and ⁇ 9 desaturylase gene. , ⁇ 12 desaturase gene and the like.
- the ⁇ 5 desaturylase gene includes genes derived from Morcella 'alpina (Lipids, 34 (7), 649 (1999)) and human (J. Biol. Chem., 274, 471 (1999)).
- ⁇ 6 desaturase gene includes Morcella 'alpina (Lipids, 34 (7), 649 (1999)), nematode (C. elegans) (Biochem. J., 330, 611 (1998)), plant
- Examples of the ⁇ 9 desaturylase gene include genes derived from Morcella 'alpina (Lipids, 34 (7), 649 (1999)) and Saccharomyces' cerepiche.
- Examples of the ⁇ 12 desaturylase gene include Morcella alpina (Lipids, 34 (7), 649 (1999)), Mucor 'Luxi, and plant (Borago officinallis) (Proc. Natl. Acad. Sci. USA, 94, 4211). (1997)) and human (J, Biol. Chem., 274, 471 (1999)).
- Each of the above genes is, for example, an oligonucleotide prepared based on a known nucleotide sequence. It can be obtained by amplifying from a chromosomal DNA or cDNA library of each organism by PCR using a nucleotide as a primer.
- a plasmid pYES2 / r24a (see FIG. 1) containing the rat ⁇ 6 desaturylase gene described in Biochem. Biophys. Res. Commun., 255 (3), 575 (1999) was used. used.
- These genes and plasmids can be obtained in the same manner as described in the literature.
- Plasmid pYES2 / r24a has been accorded a contract number FE RM BP-7100 to the Institute of Biotechnology and Industrial Technology, Ministry of International Trade and Industry (ZIP 1-3, Tsukuba East, Ibaraki, Japan 305-8566 Japan). It can be obtained from Saccharomyces. Cerevisiae SFS-2 strain deposited as No. 7 by the usual method for preparing plasmid.
- the nucleotide sequence of the rat ⁇ 6 desaturase gene contained in pYES2 / r24a and the amino acid sequence that can be encoded by the nucleotide sequence are shown in SEQ ID NOs: 1 and 2.
- the expression vector for introducing the fatty acid desaturase gene into the lipid-secreting microorganism to express the foreign gene is not particularly limited, and a suitable vector according to the host microorganism may be selected.
- a suitable vector according to the host microorganism for example, in Saccharomyces cerevisiae, YI p-type vector, ⁇ -type vector, YRp-type vector, YCp-type vector and the like are known, and any of them can be used. Experimental Methods for Molecular Genetics, P123-132 (1996)).
- a promoter for expressing the fatty acid desaturase gene when a promoter specific to the gene functions in the host microorganism, the promoter can be used, but the promoter does not function or is insufficient.
- a promoter that functions efficiently in the host microorganism may be used.
- the promoters of Saccharomyces cerevisiae include galactose kinase (GAL1), alcohol dehydrogenase (ADH), and glyceraldehyde. Promoters such as phosphate dehydrogenase (GAP-DH), acid phosphatase (PH05) and galactose assimilating enzyme (GAL) are known.
- Lipids can be produced by culturing the microorganism of the present invention in a liquid medium and accumulating lipids in the medium. Lipids include unsaturated fatty acids.
- the type of lipid produced by the present invention depends on the type of host microorganism and the type of fatty acid desaturase. For example, a ⁇ 12 desaturase gene was introduced into a lipid secreting strain that had the ability to produce oleic acid (C18: 2 ⁇ 9,12) but not the ability to produce linoleic acid (C18: 2 ⁇ 9,12). In this case, extracellular production of linoleic acid (C18: 1 ⁇ 9) becomes possible.
- the medium for culturing the microorganism of the present invention is not particularly limited, and various media containing a carbon source, a nitrogen source, inorganic ions, and the like can be used.
- Examples of the main carbon source include sugars such as glucose, sucrose, and fructose; alcohols such as ethanol and glycerin; and amino acids such as glutamic acid and aspartic acid.
- Examples of the nitrogen source include ammonia, ammonium sulfate, ammonium acetate, ammonium nitrate, ammonium chloride, yeast extract, meat extract, peptone, casein hydrolyzate, corn steep liquor, and the like.
- Examples of the inorganic ion include potassium ion, magnesium ion, iron ion, manganese ion, sodium ion, zinc ion, copper ion, molybdenum ion, iodine ion and the like.
- the culture medium contains surfactants such as polyoxyethylene (20) cetyl ether (Brij-58) and polyglycol ether (nonionic) surfactants (for example, Tergitol NP-40). It is preferable to add 0.01-1.
- surfactants such as polyoxyethylene (20) cetyl ether (Brij-58) and polyglycol ether (nonionic) surfactants (for example, Tergitol NP-40). It is preferable to add 0.01-1.
- a precursor corresponding to the lipid to be produced specifically, a lipid which is a substrate of the fatty acid desaturase is added to the medium as needed.
- the lipid added to the medium does not necessarily need to be free fatty acids, but may be triglycerides or the like.
- an inducer is required for the expression of the fatty acid desaturase gene
- the inducer is added to the medium.
- the GAL1 promoter galactose is added to the medium.
- Culture conditions may be appropriately set depending on the type of microorganism used. For example, Saccharomyces cerevisiae is cultured under aerobic conditions at 20-35 ° C, 50-300 rpm and 1-7. In the production of lipids, it is preferable to use cells in a stationary phase rather than cells in a logarithmic growth phase. Bacteria that have entered the stationary phase due to nitrogen source deficiency use the carbon source in the medium for lipid synthesis, so that the equivalent lipid yield is improved, which is preferable.
- Preferable culture media and culture conditions include, for example, a culture medium in which the ammonium sulfate is changed to 0.05% in a low nitrogen source medium described below, a YPD medium, or a cell cultured in a high nitrogen source medium described below, in a low nitrogen source medium. It shows high extracellular lipid productivity in cultures transferred to E. coli.
- lipids from the culture for example, unnecessary substances such as cells are removed from the culture by centrifugation, filtration, and the like, and the resulting culture supernatant is extracted with a suitable solvent.
- the solvent include chloroform, methylene chloride, carbon tetrachloride, halogenated lower alkanes such as 1,2-dichloroethane, and aromatic hydrocarbons such as benzene and xylene.
- the amount of the solvent is not particularly limited as long as the lipid can be sufficiently extracted, but is usually 100 m 1 to 1 L per 1 L of the culture supernatant.
- FIG. 1 is a diagram showing the structure of plasmid pYES2 / r24a. BEST MODE FOR CARRYING OUT THE INVENTION
- the present invention will be described more specifically with reference to examples.
- the composition of the medium and the like used in this example is as follows:
- Saccharomyces cerevisiae strain CG378 obtained from American 'type cultivation collection (ATCC 204664) was cultured in a 10 ml YPD medium at 30 ° C and 100 rpm with shaking for 16 hours. After completion of the culture, the cells were collected by centrifugation (3,000 rpm, 5 minutes). The cells were suspended in 5 ml of 0.2 M phosphate buffer (pH 8.0), and then collected by centrifugation (30000 rpm, 5 minutes) to wash the cells. Thereafter, the cells were mutated by suspending the cells in 10 ml of the EMS solution and gently shaking at 30 ° C. for 30 minutes. The mutation treatment was stopped by adding 9.8 ml of a 6% sodium hyposulfite solution to the EMS treatment solution and allowing it to stand for 10 minutes. In the mutation treatment, a survival rate of 15% was used as a standard.
- the cells mutated as described above are collected by centrifugation (30000 rpm, 5 minutes), inoculated into 50 ml of a high nitrogen source medium, and inoculated at 100 rpm at 30 ° C.
- the cells were cultured with shaking for 6 hours. After culturing, the cells are washed by repeating centrifugation (30000 rpm, 5 minutes) and suspension in 5 ml of 0.2 M phosphate buffer (pH 8.0) twice. did.
- the cells were inoculated into 50 ml of a low nitrogen source medium, and cultured with shaking at 30 ° C. and 100 rpm for 16 hours.
- the cells were collected by centrifugation (3000 rpm, 5 minutes) and suspended in a 2% glucose solution (cell concentration: 2 ⁇ 10 8 cells / m 1).
- a 0.25 M sucrose solution was prepared by dissolving 0.2 ml of this suspension in Percol (Pharmacia) at 100%, 90%, 80% and 70 ° / 0 , respectively.
- Percol Percol
- the high specific gravity strain obtained as described above was spread on a YPD plate medium and cultured at 30 ° C for 3 days. After colony formation, UV irradiation was performed for 15 minutes using a 15 W sterilizing lamp at a distance of 50 cm. Next, the oleate-requiring mutant was added to this plate medium. Overlaid with a 1 0 5 cells / m 1 comprising suspending soft agar medium (I) 1 0 m l (KD 1 1 5 strains, candy Li Kang Type Culture Collection (accession numbers ATCC 2 0 4 9 9 1) available from) Then, a mutant strain requiring oleic acid grew around and formed a halo. This mutant strain was designated as SFS-1 strain.
- the mutant obtained in ⁇ 1> was inoculated into 200 ml of medium A and cultured with shaking at 200 rpm at 30 ° C. for 2 hours. After completion of the culture, the wet cells were separated by centrifugation (2400 X g, 10 minutes). 100 ml of sterile distilled water was added to the wet cells, mixed, centrifuged again (as above), and the cells were washed. The cells were inoculated into 100 ml of the medium B with dried cells at a concentration of about 5 g / L, and cultured with shaking at 30 ° C. and 200 rpm for 96 hours.
- the cells in the culture broth and the culture supernatant were separated by centrifugation (as described above), and the culture supernatant was extracted three times using a 30 ml 1-hole form (total 90 m). 1).
- the extract was concentrated by evaporating the black-mouthed form, and the extract was separated by TLC.
- Plasmid pYES2 / r24a is obtained by linking a sequence containing the coding region of cDNA (1335 bp) of rat-derived ⁇ 6 desaturylase to yeast expression vector pYES2 (Invitrogen).
- pYES2 contains the Saccharomyces cerevisiae GAL1 promoter and the CYC1 promoter, and the cDNA fragment downstream of the GAL1 promoter is expressed in yeast under the control of this promoter.
- this PYES2 is a multicloning site containing a replication origin of 2 ⁇ mDNA that can be replicated in yeast and URA3 as a marker gene in yeast, HindIII and BamHK Xbal sites as a cloned site, and Escherichia coli. It comprises an ampicillin resistance gene as a marker gene and an origin of replication capable of replicating in Escherichia coli.
- the plasmid pYES2 / r24a was introduced into the Saccharomyces cerevisiae lipid-secreting mutant strain SFS-1 according to the lithium acetate method (Itoh et al., J. Bacteriol., 153: 163-168 (1983)). .
- SFS-red was cultured in 50 ml of YPD medium at 30 for 12 hours. The cells were collected by centrifugation (2400 ⁇ g, 5 minutes), suspended in 50 ml of TE buffer (10 mM Tris-HCl, lmM EDTA), and pelletized again by centrifugation.
- This pellet was resuspended in approximately 1 ml of TE buffer, 0.5 ml of 0.5 ml of 0.2 M lithium acetate solution was added to 0.5 ml of the suspension, and the suspension was added at 30 ° C. Shake gently for hours. After shaking, a 10 ⁇ 1 plasmid solution (containing about 10 ⁇ g of pYES2 / r24a DNA) was added to the above lithium acetate-bacterium mixture, and the mixture was allowed to stand at 30 ° C for 30 minutes. Next, polyethylene glycol 400 was added to a final concentration of about 35% (w / v) and mixed. After maintaining the cell solution at 30 ° C.
- the cells were collected by centrifugation (2400 ⁇ g, 5 minutes).
- the cell pellet obtained by centrifugation is suspended in 0.2 ml of TE buffer (same as above), and 0.1 ml of this is spread on the following medium (a), which is a synthetic medium containing no plastic. And incubate at 30 ° C for 3 days was done.
- the cells in the culture solution were removed by centrifugation at 3 OOOrpm.
- 30 ml of black-mouthed form was added to the culture supernatant, and extraction processing was performed three times (a total of 90 ml).
- 5 mg of margaric acid was added as an internal standard substance to the black-mouthed form extract, the extract was concentrated by evaporating chloroform, and 1 ml of a 7% boron trifluoride / methanol solution was added. By heating for 10 minutes, methyl esterification of the free fatty acid was performed.
- Example 1 Investigation of the production of arlinolenic acid by the transformant under the conditions in which ⁇ 6 desaturylase cDNA was not expressed Example 1 was repeated except that the above-mentioned medium (b) was replaced with a medium excluding galactose.
- the SFS-2 strain was cultured in the same manner as in step 3. The acid was measured. As a result, arlinolenic acid was not confirmed in any of the culture supernatant and the cells. From this, it was confirmed that the expression of ⁇ 6 desaturase was essential for the production of arisolenic acid and extracellular secretion.
- Example 4 Bovine culture medium of arlinolenic acid using resting cells of SFS-2 strain (c) 300 ml of SFS-2 strain was inoculated, cultured at 30 ° C for 72 hours, and centrifuged at 3000 rpm. The grown cells were collected.
- the cell pellet was washed with 100 ml of 0.1 M potassium phosphate buffer (pH 7.0) (the cells were suspended and then collected by centrifugation). Using a part of this cell pellet, the medium (d) having the composition was inoculated with dried cells at a concentration of 5 g / L, and cultured at 30 ° C for 144 hours. After the completion of the culture, arlinolenic acid in the culture supernatant and cells was measured in the same manner as in Example 3. As a result, 70 mg / L of linolenic acid was confirmed in the culture supernatant.
- 0.1 M potassium phosphate buffer pH 7.0
- Example 5 Examination of production of cis-6, 9, 12, 15-octanedecatetraenoic acid by SFS-2 strain under conditions for expressing mu 6 desaturylase cDNA Fatty acid was measured in the same manner as in Example 3. As a result, 22 mg / L of cis-6,9,12,15-octadecatetraenoic acid was confirmed in the culture supernatant. On the other hand, no accumulation of cis-6,9,12,15-octadecatetetraenoic acid was observed in the cells.
- ⁇ 6 desaturylase is essential for the production and extracellular secretion of cis_6,9,12,15-year-old kutadecatetraenoic acid.
- INDUSTRIAL APPLICABILITY According to the present invention, a fatty acid desaturase gene is introduced, and unsaturated fatty acids such as lipids, in particular, A secreted microorganism and a method for producing lipid using the microorganism are provided.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2000234588A AU2000234588A1 (en) | 2000-03-31 | 2000-03-31 | Process for producing lipids and lipid-secreting microorganisms |
PCT/JP2000/002129 WO2001075069A1 (fr) | 2000-03-31 | 2000-03-31 | Procede de production de lipides et micro-organismes secretant des lipides |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2000/002129 WO2001075069A1 (fr) | 2000-03-31 | 2000-03-31 | Procede de production de lipides et micro-organismes secretant des lipides |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001075069A1 true WO2001075069A1 (fr) | 2001-10-11 |
Family
ID=11735875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2000/002129 WO2001075069A1 (fr) | 2000-03-31 | 2000-03-31 | Procede de production de lipides et micro-organismes secretant des lipides |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2000234588A1 (ja) |
WO (1) | WO2001075069A1 (ja) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004031395A1 (es) * | 2002-10-04 | 2004-04-15 | Consejo Superior De Investigaciones Científicas | Procedimiento de producción de ácidos grasos poliinsaturados con levaduras por incorporación de sustratos olefínicos o acetilénicos |
US7736884B2 (en) | 2004-06-04 | 2010-06-15 | Fluxome Sciences A/S | Metabolically engineered Saccharomyces cells for the production of polyunsaturated fatty acids |
US7807849B2 (en) | 2004-04-22 | 2010-10-05 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US7834250B2 (en) | 2004-04-22 | 2010-11-16 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US8816111B2 (en) | 2012-06-15 | 2014-08-26 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising polyunsaturated fatty acids |
US9718759B2 (en) | 2013-12-18 | 2017-08-01 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising docosapentaenoic acid |
US9938486B2 (en) | 2008-11-18 | 2018-04-10 | Commonwealth Scientific And Industrial Research Organisation | Enzymes and methods for producing omega-3 fatty acids |
US10005713B2 (en) | 2014-06-27 | 2018-06-26 | Commonwealth Scientific And Industrial Research Organisation | Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids at the sn-2 position |
EP2840131B1 (en) * | 2006-05-19 | 2019-10-02 | REG Life Sciences, LLC | Production of fatty acids and derivatives thereof |
US10513717B2 (en) | 2006-08-29 | 2019-12-24 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of fatty acids |
-
2000
- 2000-03-31 AU AU2000234588A patent/AU2000234588A1/en not_active Abandoned
- 2000-03-31 WO PCT/JP2000/002129 patent/WO2001075069A1/ja active Application Filing
Non-Patent Citations (2)
Title |
---|
AKI T. ET AL.: "Molecular cloning and functional characterization of rat delta-6 fatty acid desaturase", BIOCHEM. BIOPHYS. RES. COMMUN., vol. 255, 1999, pages 575 - 579, XP002929684 * |
MIYAKAWA T. ET AL.: "Isolation and characterization of a mutant of candida-lipolytica which excretes long chain fatty-acids", AGRIC. BIOL. CHEM., vol. 48, 1984, pages 499 - 504, XP002929685 * |
Cited By (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004031395A1 (es) * | 2002-10-04 | 2004-04-15 | Consejo Superior De Investigaciones Científicas | Procedimiento de producción de ácidos grasos poliinsaturados con levaduras por incorporación de sustratos olefínicos o acetilénicos |
ES2204328A1 (es) * | 2002-10-04 | 2004-04-16 | Consejo Sup. De Invest. Cientificas | Procedimiento de produccion de acidos grasos polinsaturados con levaduras por incorporacion de sustratos olefinicos o acetilenicos. |
US9453183B2 (en) | 2004-04-22 | 2016-09-27 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cell |
US7834250B2 (en) | 2004-04-22 | 2010-11-16 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US9458410B2 (en) | 2004-04-22 | 2016-10-04 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cell |
US7932438B2 (en) | 2004-04-22 | 2011-04-26 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US8071341B2 (en) | 2004-04-22 | 2011-12-06 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US8106226B2 (en) | 2004-04-22 | 2012-01-31 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US8158392B1 (en) | 2004-04-22 | 2012-04-17 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US9994880B2 (en) | 2004-04-22 | 2018-06-12 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cell |
US11220698B2 (en) | 2004-04-22 | 2022-01-11 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US11597953B2 (en) | 2004-04-22 | 2023-03-07 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US9970033B2 (en) | 2004-04-22 | 2018-05-15 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cell |
US7807849B2 (en) | 2004-04-22 | 2010-10-05 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US8853432B2 (en) | 2004-04-22 | 2014-10-07 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cell |
US10781463B2 (en) | 2004-04-22 | 2020-09-22 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US9963723B2 (en) | 2004-04-22 | 2018-05-08 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US10443079B2 (en) | 2004-04-22 | 2019-10-15 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cell |
US9926579B2 (en) | 2004-04-22 | 2018-03-27 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cell |
US9951357B2 (en) | 2004-04-22 | 2018-04-24 | Commonweatlh Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cell |
US7736884B2 (en) | 2004-06-04 | 2010-06-15 | Fluxome Sciences A/S | Metabolically engineered Saccharomyces cells for the production of polyunsaturated fatty acids |
EP2840131B1 (en) * | 2006-05-19 | 2019-10-02 | REG Life Sciences, LLC | Production of fatty acids and derivatives thereof |
US10513717B2 (en) | 2006-08-29 | 2019-12-24 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of fatty acids |
US9938486B2 (en) | 2008-11-18 | 2018-04-10 | Commonwealth Scientific And Industrial Research Organisation | Enzymes and methods for producing omega-3 fatty acids |
US8816111B2 (en) | 2012-06-15 | 2014-08-26 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising polyunsaturated fatty acids |
US9556102B2 (en) | 2012-06-15 | 2017-01-31 | Commonwealth Scientific And Industrial Research Organisation | Process for producing ethyl esters of polyunsaturated fatty acids |
US8946460B2 (en) | 2012-06-15 | 2015-02-03 | Commonwealth Scientific And Industrial Research Organisation | Process for producing polyunsaturated fatty acids in an esterified form |
US9550718B2 (en) | 2012-06-15 | 2017-01-24 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising polyunsaturated fatty acids |
US10335386B2 (en) | 2012-06-15 | 2019-07-02 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising polyunsaturated fatty acids |
US9932289B2 (en) | 2012-06-15 | 2018-04-03 | Commonwealth Scientific And Industrial Research Ogranisation | Process for producing ethyl esters of polyunsaturated fatty acids |
US9718759B2 (en) | 2013-12-18 | 2017-08-01 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising docosapentaenoic acid |
US9725399B2 (en) | 2013-12-18 | 2017-08-08 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising long chain polyunsaturated fatty acids |
US10800729B2 (en) | 2013-12-18 | 2020-10-13 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising long chain polyunsaturated fatty acids |
US10190073B2 (en) | 2013-12-18 | 2019-01-29 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising long chain polyunsaturated fatty acids |
US10125084B2 (en) | 2013-12-18 | 2018-11-13 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising docosapentaenoic acid |
US11623911B2 (en) | 2013-12-18 | 2023-04-11 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising docosapentaenoic acid |
US10005713B2 (en) | 2014-06-27 | 2018-06-26 | Commonwealth Scientific And Industrial Research Organisation | Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids at the sn-2 position |
US10793507B2 (en) | 2014-06-27 | 2020-10-06 | Commonwealth Scientific And Industrial Research Organisation | Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids at the SN-2 position |
Also Published As
Publication number | Publication date |
---|---|
AU2000234588A1 (en) | 2001-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1878785B (zh) | 适于改变油质酵母中多不饱和脂肪酸水平的△12去饱和酶 | |
Barth et al. | Physiology and genetics of the dimorphic fungus Yarrowia lipolytica | |
US7259255B2 (en) | Glyceraldehyde-3-phosphate dehydrogenase and phosphoglycerate mutase promoters for gene expression in oleaginous yeast | |
ES2575008T3 (es) | Nuevas cepas de levadura mutantes capaces de acumular una gran cantidad de lípidos | |
US5246841A (en) | Microbial process for production of eicosapentaenoic acid | |
Michinaka et al. | Extracellular secretion of free fatty acids by disruption of a fatty acyl-CoA synthetase gene in Saccharomyces cerevisiae | |
US11345937B2 (en) | Construction of Mucor circinelloides cell factory for producing stearidonic acid and fermentation technology thereof | |
US5683898A (en) | Gene coding for eicosapentaenoic acid synthesizing enzymes and process for production of eicosapentaenoic acid | |
US11414650B2 (en) | Construction method of Mucor circinelloides cell factory for producing dihomo-gamma-linolenic acid and fermentation technology | |
EP0594868A1 (en) | Gene which codes for eicosapentaenoic acid synthetase group and process for producing eicosapentaenoic acid | |
US5798259A (en) | Gene coding for eicosapentaenoic acid synthesizing enzymes and process for production of eicosapentaenoic acid | |
WO2001075069A1 (fr) | Procede de production de lipides et micro-organismes secretant des lipides | |
MXPA06002074A (es) | Metodo de reproduccion de hongos productores de lipidos. | |
WO1998038314A1 (fr) | Gene de δ9-desaturase | |
EP1273664A1 (en) | Process for producing lipids and lipid-secreting microorganisms | |
KR100524198B1 (ko) | 오메가-9계의고도의불포화지방산및이를함유하는지질의제조방법및당해방법에사용된미생물 | |
EP0831149A1 (en) | Genes coding for biosynthetic enzyme group for icosapentaenoic acid and process for producing icosapentaenoic acid | |
Shimizu et al. | Wickerhamomyces psychrolipolyticus fa, sp. nov., a novel yeast species producing two kinds of lipases with activity at different temperatures | |
US20180363011A1 (en) | Microorganisms and use thereof for the production of diacids | |
JP2014027908A (ja) | バイオディーゼル燃料の製造方法 | |
El-Naggar et al. | Bioconversion of some agro-industrial by-products into single cell oil using Candida albicans NRRL Y-12983 and Lipomyces starkeyi NRRL Y-11557 | |
KR101837130B1 (ko) | 효모 캔디다 뷰티리 sh-14 유래의 신규 리파아제 및 그의 용도 | |
Yagi et al. | Extracellular production of palmitoleic triglycerides by a yeast, Trichosporon | |
Chen et al. | Enhancement of lipase production from hydrocarbons by mutation of Trichosporon fermentans | |
US20220056491A1 (en) | Microbial conversion of oils and fats to lipid-derived high-value products |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: RULE 69 (1) EPC |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |